Accelerate the potential of precision medicine
Accelerate, simplify and improve research and cancer diagnostics with visualization-based analysis.
Explore more
Now launched - first CE-marked test for Leukemia
We introduce the first CE-marked diagnostic test for pediatric leukemia according to the mandatory regulatory framework in Europe (IVDR). Now available for delivery and clinical use, Qlucore Diagnostics provides enhanced accuracy and marks a significant step forward in the ability to diagnose this common childhood cancer.
Get more and better answers from your data
Advances in next-generation sequencing are giving us the raw data to research, explore and improve diagnosis, with more ambition than ever. Qlucore visualization-based solutions make it easier for researchers, technicians and physicians to easily explore, interpret and make clinical decisions.
Success stories
Try before you buy
Would you like to experience Qlucore Omics Explorer or Qlucore Insights before making a purchase? You can download the trial software for PC or Mac at no cost.
DownloadFree consultation
Not sure how to get started, or which Qlucore solution best suits your needs? Contact us for advice on selecting the right software to advance your research and diagnostic goals today.
Contact usTeam Qlucore
Qlucore was founded by a multi-disciplinary team with a passion for transforming complexity into clarity—and a vision to unite research, diagnosis and care in the pursuit of precision medicine.
Find out more
How it works
Learn how easy it is to manage complex datasets and quickly gain insights and results to power your research.
Webinars
Explore analysis topics and themes in our ongoing webinar series, and sign up for notification of new ones.
First time users
If you’re new to Qlucore, take our introductory tour of set-up and operation designed to get you up and running quickly.
Get a quote
Ready to make omics data analysis faster, simpler and more powerful for your team? Contact us for a no-obligation quote.
Latest news
Qlucore Newsletter: Early Subtyping can Reduce Unclassified Lung Tumors by 80%
Unclassified tumors delay analysis and decision-making.
Read more
Qlucore Newsletter: Find Patterns and Insights in Your Data
Heatmaps are powerful visualizations. They can help you uncover hidden patterns and insights in your data.
Read more
Qlucore Newsletter: RNA Sequencing is Transforming Diagnostics
RNA sequencing (RNA-seq) is rapidly proving its value in diagnostics, offering insights into gene expression, fusions, and mutations.
Read more
Qlucore Newsletter: Qlucore Launches First CE-Marked Diagnostic Test for Pediatric Leukemia
Qlucore has launched the first CE-marked RNA-seq based diagnostic test for pediatric leukemia under Europe’s IVDR framework.